Skip to main content
OpenTrials

Clinical trial condition

Fallopian Tube Diseases

Explore clinical trials studying Fallopian Tube Diseases. Study availability and eligibility vary by location and protocol.

598 public trials 89 recruiting studies
Refine in advanced search Browse all conditions

Fallopian Tube Diseases trial results

Completed

Genomic BRCA and Extensive ovArian Cancer Testing

NCT04027868

Conditions
Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +21 more
Locations
  • Centre de Radiothérapie et d'Oncologie de Moyenne Garonne (CROMG) Agen, France
  • Hôpital Privé d'Aix en Provence Aix-en-Provence, France
  • Centre Hospitalier Général d'Aix-en-Provence Aix-en-Provence, France
  • CHU Amiens Amiens, France
View all 137 locations
View Trial Details
Completed

Multi-Centre Observational Study of Maintenance Niraparib in Treatment of Ovarian CanceR

NCT04295577

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +17 more
Locations
  • Royal United Hospitals Bath Bath, United Kingdom
  • Belfast Health & Social Care Trust Belfast, United Kingdom
  • University Hospitals Birmingham NHS Foundation Trust Birmingham, United Kingdom
  • University Hospitals Bristol NHS Foundation Trust Bristol, United Kingdom
View all 15 locations
View Trial Details
Completed

Study of Chemotherapy With Pembrolizumab (MK-3475) Followed by Maintenance With Olaparib (MK-7339) for the First-Line Treatment of Women With BRCA Non-mutated Advanced Epithelial Ovarian Cancer (EOC) (MK-7339-001/KEYLYNK-001/ENGOT-ov43/GOG-3036)

NCT03740165

Conditions
Abdominal Neoplasms, Adnexal Diseases, Digestive System Diseases, +22 more
Locations
  • University of Alabama at Birmingham (UAB) ( Site 0036) Birmingham, Alabama, United States
  • University of Arizona Cancer Center ( Site 0074) Tucson, Arizona, United States
  • Disney Family Cancer Center ( Site 0042) Burbank, California, United States
  • Kaiser Permanente Oncology Clinical Trial -Oakland ( Site 0077) Oakland, California, United States
View all 227 locations
View Trial Details
Completed

A Study of MORAb-202 Versus Investigator's Choice Chemotherapy in Female Participants With Platinum-resistant High-grade Serous (HGS) Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

NCT05613088

Conditions
Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +19 more
Locations
  • Local Institution - 0065 Sacramento, California, United States
  • Local Institution - 0025 San Francisco, California, United States
  • Local Institution - 0078 Whittier, California, United States
  • Local Institution - 0081 South Bend, Indiana, United States
View all 50 locations
View Trial Details
Completed

Upfront Systematic Tumour BRCA Testing in Patients With High Grade Serous or Endometrioid Ovarian, Fallopian Tube or Primary Peritoneal Cancer (HGSEC): The t-BRCA Study

NCT06274541

Conditions
Adnexal Diseases, Endometrioid Carcinoma Ovary, Fallopian Tube Cancer, +13 more
Locations
  • Mater Misericordiae University Hospital / Mater Private Hospital Dublin, Leinster, Ireland
  • St James's Hospital Dublin, Leinster, Ireland
  • Bon Secours Cork, Munster, Ireland
  • Cork University Hospital Cork, Munster, Ireland
View Trial Details
Completed

Metformin and Chemotherapy in Treating Patients With Stage III-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

NCT02122185

Conditions
Adnexal Diseases, Brenner Tumor, Carcinoma, +57 more
Locations
  • University of Alabama Birmingham, Alabama, United States
  • Mitchell Cancer Institute - University of South Alabama Mobile, Alabama, United States
  • City of Hope Duarte, California, United States
  • NCH Medical Group- Northwest Community Hospital Arlington Heights, Illinois, United States
View Trial Details

Related conditions